HomeCompareMCVEY vs PLD

MCVEY vs PLD: Dividend Comparison 2026

MCVEY yields 1.01% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.48M in total portfolio value
10 years
MCVEY
MCVEY
● Live price
1.01%
Share price
$16.55
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$107.74
Full MCVEY calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — MCVEY vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCVEYPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCVEY + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCVEY pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCVEY
Annual income on $10K today (after 15% tax)
$85.78/yr
After 10yr DRIP, annual income (after tax)
$91.58/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,467,879.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCVEY + PLD for your $10,000?

MCVEY: 50%PLD: 50%
100% PLD50/50100% MCVEY
Portfolio after 10yr
$3.26M
Annual income
$2,628,271.96/yr
Blended yield
80.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MCVEY
No analyst data
Altman Z
1.8
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCVEY buys
0
PLD buys
0
No recent congressional trades found for MCVEY or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCVEYPLD
Forward yield1.01%3.18%
Annual dividend / share$0.17$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$21.1K$6.50M
Annual income after 10y$107.74$5,256,436.18
Total dividends collected$1.0K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MCVEY vs PLD ($10,000, DRIP)

YearMCVEY PortfolioMCVEY Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,801$100.91$11,255$555.24$454.00PLD
2$11,659$101.86$13,062$1,018.59$1.4KPLD
3$12,578$102.76$15,903$1,926.67$3.3KPLD
4$13,562$103.61$20,839$3,823.32$7.3KPLD
5$14,615$104.41$30,464$8,166.08$15.8KPLD
6$15,744$105.16$52,054$19,457.30$36.3KPLD
7$16,952$105.86$109,886$54,188.93$92.9KPLD
8$18,245$106.53$304,030$186,451.18$285.8KPLD
9$19,629$107.16$1,166,125$840,813.32$1.15MPLD
10$21,111$107.74$6,504,190$5,256,436.18$6.48MPLD

MCVEY vs PLD: Complete Analysis 2026

MCVEYStock

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Full MCVEY Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this MCVEY vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCVEY vs SCHDMCVEY vs JEPIMCVEY vs OMCVEY vs KOMCVEY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.